Priority 19 from the Blood Transfusion and Blood Donation PSP
| UNCERTAINTY: At what haemoglobin level [blood count] should a patient who has experienced a haematological (blood or bone marrow) disorder receive a blood transfusion? (JLA PSP Priority 19) | |
|---|---|
| Overall ranking | 19 |
| JLA question ID | 0063/19 |
| Explanatory note | Not available for this PSP |
|
Evidence |
No systematic review evidence available |
| Health Research Classification System category | Generic Health Relevance |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | Patients with cancer/haematological malignancies/leukaemia/MDS, and production failure, what are the optimal red cell transfusion strategies? ~ Does transfusion to a haemoglobin >100 or >110 or >120 improve the quality of life of MDS patients? ~ What is the optimal red cell transfusion threshold for patients with acute leukaemia receiving intensive treatment? |
| Submitted by | 1 relative or carer of blood recipient ~ 3 blood donors ~ 4 health professionals ~ 1 other (question not from survey) |
| PSP information | |
|---|---|
| PSP unique ID | 0063 |
| PSP name | Blood Transfusion and Blood Donation |
| Total number of uncertainties identified by this PSP | 51 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | 28 February 2018 |